Shares of Immuron Ltd. (IMRN) are rallying over 48% in pre-market today, after the company announced that it has partnered with CSIRO to produce a new oral therapeutic for clinical evaluation by the US Department of Defense.
from RTT - Before the Bell https://ift.tt/3eic0rw
via IFTTT
No comments:
Post a Comment